Clinical Trial Update: Study of the Effectiveness of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Fibrin to Treat Chronic Wounds [Phase 1]

View source ↗

Summary

Phase 1 study evaluating autologous bone marrow-derived mesenchymal stem cells in fibrin for chronic wounds has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wounds

Drugs mentioned

• Autologous bone marrow-derived mesenchymal stem cells in fibrin (bone marrow-derived mesenchymal stem cells in fibrin)

Snippet

Sponsor: Roger Williams Medical Center | Conditions: Non Healing Wounds | Phase 1 | Status: TERMINATED